2009
DOI: 10.1111/j.1600-0536.2008.01473.x
|View full text |Cite
|
Sign up to set email alerts
|

Read‐across to rank skin sensitization potential: subcategories for the Michael acceptor domain

Abstract: Background: Eliminating animal testing for skin sensitization is a significant challenge in consumer safety risk assessment. To be able to perform resilient risk assessments in the future, one will need alternative approaches to fill the data gaps.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
41
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(42 citation statements)
references
References 31 publications
1
41
0
Order By: Relevance
“…This was demonstrated in the glutathione chemoassay where compounds with similar RC50 values were shown to have a 10-fold difference in rate constants (22). The allocation of Michael acceptors into subcategories of the domain (23) demonstrates this structural diversity. Data from the NBT-DNCB reaction shows that it was an outlier (Figure 5b).…”
Section: Discussionmentioning
confidence: 96%
“…This was demonstrated in the glutathione chemoassay where compounds with similar RC50 values were shown to have a 10-fold difference in rate constants (22). The allocation of Michael acceptors into subcategories of the domain (23) demonstrates this structural diversity. Data from the NBT-DNCB reaction shows that it was an outlier (Figure 5b).…”
Section: Discussionmentioning
confidence: 96%
“…Screening point values are also within an order of magnitude for anionic surfactant data from ECO-TOX and for alkyl sulfates (also anionic) from IUCLID and SIDS dossiers. Recently, several publications have discussed various techniques described as read-across approaches to hazard identification [25][26][27]. Goals of read-across approaches may include the use of existing information to provide an ecotoxicological concentration estimate to serve as a screening point value (SPV) for establishment of a safety value, reduce uncertainty surrounding risk management decisions, and allow prioritization of further testing needs.…”
Section: Discussionmentioning
confidence: 99%
“…This, of course, requires that the errors introduced due to assay differences are more than compensated for by building a model on a larger, more diverse dataset. Examples of this approach include modeling studies by Schultz et al who used both LLNA and glutathione binding data to build models for skin sensitization [91]. A similar approach was taken in the TIMES-SS program where three different sources of in vivo data, derived from multiple animals, were used in modeling skin sensitization [92].…”
Section: Importance Of Data Treatmentmentioning
confidence: 98%